Expanded Product Jurisdiction Role For OCP Formalized In June 23 Final Rule
This article was originally published in The Gray Sheet
Executive Summary
FDA's Principal Associate Commissioner must agree to any nonconsensual change in jurisdiction once a letter of designation has been issued, a 1June 23 final rule explains